Medicare’s PET project
This article was originally published in The Gray Sheet
Executive Summary
CMS seeks comments on alternatives to its "indication-by-indication" approach to determining whether positron emission tomography scans for cancer are reasonable and necessary. The Oct. 14 solicitation responds to extensive criticism by stakeholders. Despite an April 2004 deadline, CMS is still evaluating evidence for granting national coverage to brain, testicular, small-cell lung, cervical and pancreatic cancers (1"The Gray Sheet" Sept. 13, 2004, p. 4)...